Literature DB >> 1543214

Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients.

R R MacGregor, A S Morgan, A L Graziani, N A Pietroski, I Frank, M N Braffman, J J Stern, R M Buckley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1543214     DOI： 10.1016/0002-9343(92)90122-r

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  1 in total

1.  Predicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary Pneumocystis carinii pneumonia prophylaxis.

Authors:  S Hennessy; B L Strom; J A Berlin; P J Brennan
Journal:  J Gen Intern Med       Date:  1995-07       Impact factor: 5.128
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.